192 related articles for article (PubMed ID: 32954433)
1. Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature.
Marker DF; Kofler JK; Mettenburg JA; Agha ME; Wiley CA
J Neuropathol Exp Neurol; 2020 Oct; 79(10):1115-1121. PubMed ID: 32954433
[TBL] [Abstract][Full Text] [Related]
2. Multifocal necrotizing leukoencephalopathy: An unusual complication of acute leukemia.
Robb J; Chalmers L; Rojiani A; Chamberlain M
Arch Neurol; 2006 Jul; 63(7):1028-9. PubMed ID: 16831976
[No Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy after CAR T therapy.
Sdrimas K; Diaz-Paez M; Camargo JF; Lekakis LJ
Int J Hematol; 2020 Jul; 112(1):118-121. PubMed ID: 32125605
[TBL] [Abstract][Full Text] [Related]
4. Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma.
Nie EH; Ahmadian SS; Bharadwaj SN; Acosta-Alvarez L; Threlkeld ZD; Frank MJ; Miklos DB; Monje M; Scott BJ; Vogel H
J Neuropathol Exp Neurol; 2023 Jan; 82(2):160-168. PubMed ID: 36592076
[TBL] [Abstract][Full Text] [Related]
5. Fatal neurotoxicity after chimeric antigen receptor T-cell therapy: An unexpected case of fludarabine-associated progressive leukoencephalopathy.
Winter SF; Martinez-Lage M; Clement NF; Hochberg EP; Dietrich J
Eur J Cancer; 2021 Feb; 144():178-181. PubMed ID: 33360262
[No Abstract] [Full Text] [Related]
6. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
[TBL] [Abstract][Full Text] [Related]
7. Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia.
Danylesko I; Chowers G; Shouval R; Besser MJ; Jacoby E; Shimoni A; Nagler A; Avigdor A
Curr Res Transl Med; 2020 Jan; 68(1):17-22. PubMed ID: 31882377
[TBL] [Abstract][Full Text] [Related]
8. Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden.
Qu C; Ping N; Kang L; Liu H; Qin S; Wu Q; Chen X; Zhou M; Xia F; Ye A; Kong D; Li C; Yu L; Wu D; Jin Z
J Immunother; 2020 Jan; 43(1):32-37. PubMed ID: 31219975
[TBL] [Abstract][Full Text] [Related]
9. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
10. Rapid and sustained response to Chimeric Antigen Receptor T cell therapy in double hit diffuse large B cell lymphoma.
Deol A; Uberti J
Am J Hematol; 2020 Mar; 95(3):333-334. PubMed ID: 31429117
[No Abstract] [Full Text] [Related]
11. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.
Rubinstein LJ; Herman MM; Long TF; Wilbur JR
Cancer; 1975 Feb; 35(2):291-305. PubMed ID: 1053934
[TBL] [Abstract][Full Text] [Related]
12. Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES).
Gonzalez Castro LN; Dietrich J; Forst DA
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1917-1918. PubMed ID: 30539279
[No Abstract] [Full Text] [Related]
13. Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases.
Anders KH; Becker PS; Holden JK; Sharer LR; Cornford ME; Hansen LA; Hamilton R; Vinters HV
Hum Pathol; 1993 Aug; 24(8):897-904. PubMed ID: 8375859
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy.
Re D; Bamborschke S; Feiden W; Schröder R; Lehrke R; Diehl V; Tesch H
Bone Marrow Transplant; 1999 Feb; 23(3):295-8. PubMed ID: 10084263
[TBL] [Abstract][Full Text] [Related]
15. Necrotizing leukoencephalopathy and treated multiple myeloma. An autopsy case without intrathecal chemotherapy or irradiation of the brain.
Mizutani T; Morimatsu Y; Hayakawa K
Acta Pathol Jpn; 1984 May; 34(3):655-62. PubMed ID: 6464755
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy.
Lapidus AH; Anderson MA; Harrison SJ; Dickinson M; Kalincik T; Lasocki A
Leuk Lymphoma; 2022 Oct; 63(10):2364-2374. PubMed ID: 35570737
[TBL] [Abstract][Full Text] [Related]
17. Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage.
Jabbour E; Sasaki K; Ravandi F; Huang X; Short NJ; Khouri M; Kebriaei P; Burger J; Khoury J; Jorgensen J; Jain N; Konopleva M; Garcia-Manero G; Kadia T; Cortes J; Jacob J; Montalbano K; Garris R; O'Brien S; Kantarjian HM
Cancer; 2018 Oct; 124(20):4044-4055. PubMed ID: 30307611
[TBL] [Abstract][Full Text] [Related]
18. Necrotizing leukoencephalopathy following CHOP chemotherapy.
Blaes AH; Santa-Cruz KS; Lee CK; Hui SK; Peterson BA
Leuk Res; 2008 Oct; 32(10):1611-4. PubMed ID: 18378307
[TBL] [Abstract][Full Text] [Related]
19. Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
Zhou X; Tu S; Wang C; Huang R; Deng L; Song C; Yue C; He Y; Yang J; Liang Z; Wu A; Li M; Zhou W; Du J; Guo Z; Li Y; Jiao C; Liu Y; Chang LJ; Li Y
Front Immunol; 2020; 11():564099. PubMed ID: 33329526
[TBL] [Abstract][Full Text] [Related]
20. CAR-T Cell Therapy-Related Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia: Spectrum of Imaging Findings.
Tan AP
Pediatr Neurol; 2020 Oct; 111():51-58. PubMed ID: 32951662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
